New injection aims to shrink bulging eyes in thyroid condition

NCT ID NCT05524571

Ongoing Disease control Sponsor: Immunovant Sciences GmbH Source: ClinicalTrials.gov ↗

Summary

This study is testing whether weekly injections of an experimental drug called batoclimab can reduce eye bulging and inflammation in people with active Thyroid Eye Disease. About 100 participants will receive either the drug or a placebo for 24 weeks to see which is better at pulling the eyes back into the socket. The main goal is to see if the drug can reduce eye protrusion by at least 2 millimeters without worsening the other eye.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Locations

Site Number - 1512

Winston-Salem, North Carolina, 27157, United States
Site Number - 1513

Rochester, Minnesota, 55905, United States
Site Number - 1518

Milwaukee, Wisconsin, 53226, United States
Site Number - 1521

Seattle, Washington, 98104, United States
Site Number - 1524

McAllen, Texas, 78503, United States
Site Number - 1525

Portland, Oregon, 97239, United States
Site Number - 1526

Livonia, Michigan, 48152, United States
Site Number - 3605

Barcelona, 08035, Spain
Site Number - 4672

Brussels, 1070, Belgium
Site Number - 4673

Brussels, 1200, Belgium
Site Number - 4674

Liège, 4000, Belgium
Site Number - 4950

Ankara, 6100, Turkey (Türkiye)
Site Number - 4951

Istanbul, 34010, Turkey (Türkiye)
Site Number - 4952

Adana, 13860, Turkey (Türkiye)
Site Number - 6603

Mainz, Rhineland-Palatinate, 55131, Germany
Site Number - 7550

Budapest, 1133, Hungary
Site Number - 7551

Pécs, 7621, Hungary
Site Number - 7552

Pécs, 7623, Hungary
Site Number - 7565

Sydney, 2000, Australia
Site Number - 7570

Christchurch, 8013, New Zealand
Site Number - 7572

Hamilton, 3204, New Zealand
Site Number - 9200

Bratislava, 82606, Slovakia
Site Number - 9201

Bratislava, 85107, Slovakia
Site Number - 9202

Trenčín, 91101, Slovakia
Site Number - 9203

Bratislava, 81108, Slovakia
Site Number - 9302

Ventspils, LV-3601, Latvia
Site Number -1510

Sarasota, Florida, 34239, United States
Site Number -1511

Morgantown, West Virginia, 26506, United States
Site Number -1514

Torrance, California, 90502, United States
Site Number -1515

Bellaire, Texas, 77401, United States
Site Number -1516

Louisville, Kentucky, 40202, United States
Site Number -1517

San Francisco, California, 94143, United States
Site Number -1519

San Antonio, Texas, 78215, United States
Site Number -1520

Pasadena, California, 91107, United States
Site Number -1990

San Juan, 00921, Puerto Rico
Site Number -3600

Santiago de Compostela, 15706, Spain
Site Number -3601

Madrid, 28007, Spain
Site Number -3602

Barcelona, 08006, Spain
Site Number -3603

Valencia, 46026, Spain
Site Number -3604

Madrid, 28034, Spain
Site Number -3606

Seville, 41009, Spain
Site Number -4670

Ghent, B-9000, Belgium
Site Number -4671

Bruges, 8000, Belgium
Site Number -9300

Riga, LV-1006, Latvia
Site Number -9301

Ogre, LV-5001, Latvia

Conditions

Explore the condition pages connected to this study.

THYROID EYE DISEASE